Friday, August 26, 2022 8:15:54 PM
But lets suppose that's true. You're not including the tranches for future share prices into the equation.
I'm going to base this off the original conversion agreement and the recent increase of the o/s from the last Q to the current Q.
So one can assume around 10 million shares has been converted by Leonite recently. At a discounted rate of .0123, that would knock off $123,000 of their $420,000 convertable debt, leaving them with $297,000 in debt with Leonite.
However, if the next tranch gives us a 21 day low of .10, Leonite would get their discounted shares at .05. That would be a total of 5,940,000 shares left which would fully pay off the remaining debt of $297,000. Thats not a lot, and no where near the 40 million+ you're assuming.
Or if the 21 day low is .12, the total convertable debt would be 4,950,000. ($297,000 ÷ .06 = 4,950,000 shares.)
I highly doubt that this would get to a couple of pennies. But lets assume it does in the next tranch where the conversion rate is at .0123. With $297,000 left in convertable debt, the total amount in shares issued would be 24.1 million shares added to the o/s. ($297,000 ÷ .0123 = 24.1 million shares)
Again, not 40+ million shares as you said it can be. You simply havent factored in the next tranch conversion rate which will be much higher than .0123, unless you think this falls back to a couple pennies. Might I add, nor have you added the recent and suspected conversion to the equation.
Either way, whether if it's 5 million or 24 million, given the fundamentals that we have, this stock will still be justified in the dollars.
Recent BMXI News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:13:31 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 01/22/2024 11:00:56 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM